Sanjay Jain
Directeur/Membre du Conseil chez BJC Behavioral Health
Profil
Sanjay Jain has worked as a Director of Biologic Research at Xenetic Biosciences (UK) Ltd.
since 2002.
He is also currently a Director at BJC Behavioral Health and a Member of both The Controlled Release Society and the American Society of Pharmacognosy.
Postes actifs de Sanjay Jain
| Sociétés | Poste | Début |
|---|---|---|
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/01/2002 |
The Controlled Release Society
 The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Corporate Officer/Principal | - |
| American Society of Pharmacognosy | Corporate Officer/Principal | - |
BJC Behavioral Health
 BJC Behavioral Health Medical/Nursing ServicesHealth Services BJC Behavioral Health is a healthcare company based in St. Louis, MO. BJC Behavioral Health has several hospitals and medical centers in the St. Louis area, including Barnes-Jewish Hospital and St. Louis Children's Hospital. BJC Behavioral Health provides medical services, including mammography, emergency care, and COVID-19 testing. The private company also offers online resources, such as MyChart patient portal and a newsletter. The company is committed to community health improvement and outreach programs. The company was founded in 1993, and the CEO is Richard J. Liekweg. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
The Controlled Release Society
The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Commercial Services |
| American Society of Pharmacognosy | |
BJC Behavioral Health
BJC Behavioral Health Medical/Nursing ServicesHealth Services BJC Behavioral Health is a healthcare company based in St. Louis, MO. BJC Behavioral Health has several hospitals and medical centers in the St. Louis area, including Barnes-Jewish Hospital and St. Louis Children's Hospital. BJC Behavioral Health provides medical services, including mammography, emergency care, and COVID-19 testing. The private company also offers online resources, such as MyChart patient portal and a newsletter. The company is committed to community health improvement and outreach programs. The company was founded in 1993, and the CEO is Richard J. Liekweg. | Health Services |
